Publications by authors named "Noel Magnin"

Three recognized plant defense stimulators (PDS), methyl jasmonate (MeJA), benzothiadiazole (BTH) and phosphonates (PHOS), were sprayed on grapevine cuttings and conferred resistance to the biotrophic pathogen . The effects on molecular defense-related genes and polyphenol content (stilbenes and flavanols) were revealed at 6 and 8 days post-elicitation. The transcript accumulation was consistent with the signaling pathway specific to the elicitor, salicylic acid for BTH, and jasmonic acid for MeJA, with some cross-talks.

View Article and Find Full Text PDF

The worldwide increase in grapevine trunk diseases, mainly esca, represents a major threat for vineyard sustainability. Biocontrol of a pioneer fungus of esca, , was investigated here by deciphering the tripartite interaction between this trunk-esca pathogen, grapevine and the biocontrol-oomycete, . When colonizes grapevine roots, it was observed that the wood necroses caused by were significantly reduced.

View Article and Find Full Text PDF
Article Synopsis
  • Chemical fungicides are commonly used to combat grapevine diseases caused by biotrophic pathogens but have harmful environmental effects; alternative solutions include compounds that stimulate plant immune responses.
  • The "NeoViGen96" chip, a new microfluidic platform, was developed to efficiently profile the expression of 85 defense-related grapevine genes and test the efficacy of defense inducers like benzothiadiazole (BTH) and fosetyl-aluminum (FOS) against downy mildew.
  • Results showed that while BTH effectively induced resistance by activating several defense genes, FOS provided better protection likely due to its fungicidal properties, and the NeoViGen96 chip offers a reliable and cost-effective method for assessing plant defenses
View Article and Find Full Text PDF

Inositol-requiring enzyme 1 (IRE1) is a proximal endoplasmic reticulum (ER) stress sensor and a central mediator of the unfolded protein response. In a human glioma model, inhibition of IRE1alpha correlated with down-regulation of prevalent proangiogenic factors such as VEGF-A, IL-1beta, IL-6, and IL-8. Significant up-regulation of antiangiogenic gene transcripts was also apparent.

View Article and Find Full Text PDF
Article Synopsis
  • Human cytomegalovirus (HCMV) is a significant threat to immunocompromised transplant patients, prompting a study on the recombination of five HCMV genes in clinical strains.
  • Nucleotidic polymorphism was observed in various strains, revealing a notable percentage of missense mutations which may affect functionality; analysis showed patterns indicating possible recombination.
  • The findings highlight the importance of recombination in HCMV's evolutionary adaptation and its implications for infected patients.
View Article and Find Full Text PDF

Background: Human cytomegalovirus (HCMV) is the most common opportunistic pathogen infecting immunocompromised patients after transplantation. Although its immunomodulatory capacities and genomic variability participate in immune system evasion, they are poorly studied in clinical strains without culture amplification. One of HCMV immunomodulatory genes, UL40, confers HCMV-infected cells' protection from natural killer-mediated lysis through its encoded nonapeptide presented in the context of human leukocyte antigen-E.

View Article and Find Full Text PDF

Background: Variability of human cytomegalovirus (HCMV) genes counteracting immune responses is poorly investigated in non-cultured clinical strains.

Objectives: In HCMV-infected renal graft recipients, we aimed to (i) investigate the variability of four HCMV immunomodulatory genes, without any culture-related viral selection, (ii) provide evolutionary sequence data, and (iii) study co-existing HCMV variants and their evolution.

Study Design: UL18, UL40, UL111a and US3 were sequenced in 31 blood samples from 17 patients (8 with sequential samples).

View Article and Find Full Text PDF

We present here the first data available on resistance to nucleoside reverse transcriptase inhibitors (NRTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) in India. In these subtype C isolates, we have observed most of the mutations noted in reverse transcriptase (RT) for subtype B with some additional substitutions (at positions 98, 203, 208, and 221) that will warrant attention in the algorithms used.

View Article and Find Full Text PDF